Showing results (1-10 of 245) with videos related to
Sort By:
Pageof 25
Circulation Journal : Official Journal of the Japanese Circulation Society|December 6, 2008
Cardiac adiposity and global cardiometabolic risk: new concept and clinical implicationMichio ShimabukuroCureus|December 26, 2022
Acute Myocardial Infarction During the Last Part of a Triathlon: A Case ReportSatoshi Yamaguchi, Michio ShimabukuroFukushima Journal of Medical Science|April 29, 2024
2023 Fukushima Medical University International Symposium on the Fukushima Health Management Survey, "Thinking Together about Health, Life, and our Future in Fukushima"Michio Shimabukuro, Kenji KamiyaJournal of Hypertension|March 14, 2007
Effects of telmisartan on fat distribution in individuals with the metabolic syndromeMichio Shimabukuro, Hideaki Tanaka, Takeshi ShimabukuroJournal of Atherosclerosis and Thrombosis|October 6, 2005
High prevalence of metabolic syndrome among men in OkinawaHideaki Tanaka, Takeshi Shimabukuro, Michio ShimabukuroJournal of Diabetes and Its Complications|April 25, 2006
Comparison of the antioxidant and vascular effects of gliclazide and glibenclamide in Type 2 diabetic patients: a randomized crossover studyMichio Shimabukuro, Namio Higa, Nobuyuki TakasuDiabetes Research and Clinical Practice|September 26, 2021
Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspectiveHayato Tanabe, Hiroaki Masuzaki, Michio ShimabukuroCardiovascular Diabetology|May 19, 2016
Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in menMichio Shimabukuro, Namio Higa, Hiroaki Masuzaki, et al.International Journal of Cardiology|June 23, 2012
Miglitol, α-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: a randomized comparable studyMichio Shimabukuro, Moritake Higa, Ken Yamakawa, et al.Metabolism: Clinical and Experimental|May 28, 2004
Fluvastatin improves endothelial dysfunction in overweight postmenopausal women through small dense low-density lipoprotein reductionMichio Shimabukuro, Namio Higa, Tomohiro Asahi, et al.Pageof 25